Mera Pharmaceuticals, Inc. (MRPI)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 25, 2026
Mera Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2011 | FY 2010 | FY 2009 | 2008 - 2004 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '21 Jul 31, 2021 | Oct '20 Oct 31, 2020 | Oct '19 Oct 31, 2019 | Oct '11 Oct 31, 2011 | Oct '10 Oct 31, 2010 | Oct '09 Oct 31, 2009 | 2008 - 2004 |
| Cash & Equivalents | - | - | - | 0 | 0.01 | 0 | Upgrade
|
| Cash & Short-Term Investments | - | - | - | 0 | 0.01 | 0 | Upgrade
|
| Cash Growth | - | - | - | -27.36% | 89.47% | -94.16% | Upgrade
|
| Accounts Receivable | - | - | - | 0.01 | 0.01 | 0.01 | Upgrade
|
| Receivables | - | - | - | 0.01 | 0.01 | 0.01 | Upgrade
|
| Prepaid Expenses | - | - | - | 0.04 | - | - | Upgrade
|
| Other Current Assets | - | - | - | - | - | 0.02 | Upgrade
|
| Total Current Assets | - | - | - | 0.05 | 0.01 | 0.03 | Upgrade
|
| Property, Plant & Equipment | - | - | - | 0 | 0.01 | 0.2 | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.01 | 0.05 | 0.03 | Upgrade
|
| Total Assets | - | - | - | 0.07 | 0.07 | 0.26 | Upgrade
|
| Accounts Payable | 0.04 | 0.03 | 0.02 | 0.49 | 0.37 | 0.16 | Upgrade
|
| Accrued Expenses | - | - | - | 0.15 | 0.15 | 0.15 | Upgrade
|
| Short-Term Debt | - | - | - | 0.3 | 0.23 | 0.05 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | - | 0.03 | Upgrade
|
| Total Current Liabilities | 0.04 | 0.03 | 0.02 | 0.94 | 0.75 | 0.4 | Upgrade
|
| Total Liabilities | 0.04 | 0.03 | 0.02 | 0.94 | 0.75 | 0.4 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 8.38 | 8.38 | 8.38 | 7.97 | 7.97 | 7.97 | Upgrade
|
| Retained Earnings | -8.47 | -8.46 | -8.46 | -8.89 | -8.7 | -8.16 | Upgrade
|
| Treasury Stock | -0 | -0 | -0 | -0 | -0 | -0 | Upgrade
|
| Total Common Equity | -0.04 | -0.03 | -0.02 | -0.86 | -0.68 | -0.14 | Upgrade
|
| Shareholders' Equity | -0.04 | -0.03 | -0.02 | -0.86 | -0.68 | -0.14 | Upgrade
|
| Total Liabilities & Equity | - | - | - | 0.07 | 0.07 | 0.26 | Upgrade
|
| Total Debt | - | - | - | 0.3 | 0.23 | 0.05 | Upgrade
|
| Net Cash (Debt) | - | - | - | -0.29 | -0.22 | -0.05 | Upgrade
|
| Net Cash Per Share | - | - | - | -0.00 | -0.00 | -0.00 | Upgrade
|
| Filing Date Shares Outstanding | 556.8 | 556.8 | 557.3 | 556.8 | 547.27 | 547.27 | Upgrade
|
| Total Common Shares Outstanding | 556.8 | 556.8 | 557.3 | 547.27 | 547.27 | 547.27 | Upgrade
|
| Working Capital | -0.04 | -0.03 | -0.02 | -0.88 | -0.74 | -0.37 | Upgrade
|
| Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Tangible Book Value | -0.04 | -0.03 | -0.02 | -0.86 | -0.68 | -0.14 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Machinery | - | - | - | 0.11 | 0.11 | 0.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.